Protection from infection with severe acute respiratory syndrome coronavirus in a Chinese hamster model by equine neutralizing F(ab′) 2

Viral Immunology

Volumn 20, Issue 3, 2007, Pages 495-502

  Luo, Deyan ^a   Ni, Bing ^b,c   Zhao, Guangyu ^a   Jia, Zhengcai ^b   Zhou, Lili ^a   Pacal, Marek ^c   Zhang, Liangyan ^a   Zhang, Songle ^a   Xing, Li ^a   Lin, Zhihua ^c   Wang, Li ^b   Li, Jintao ^b   Liang, Yunfei ^b   Shi, Xinfu ^a   Zhao, Tingting ^b   Zou, Liyun ^b   Wu, Yuzhang ^b   Wang, Xiliang ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN F(AB')2 FRAGMENT; NEUTRALIZING ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHINESE HAMSTER; CONTROLLED STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; INFECTION PREVENTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTECTION; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VIRUS LOAD;

ANIMALS; ANTIBODIES, VIRAL; CRICETINAE; CRICETULUS; DISEASE MODELS, ANIMAL; FEMALE; HORSES; IMMUNOGLOBULIN FAB FRAGMENTS; LUNG; NEUTRALIZATION TESTS; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME;

ANIMALIA; CRICETULUS GRISEUS; EQUIDAE; SARS CORONAVIRUS;

EID: 35348890457     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2007.0038     Document Type: Article

References (34)

1. Bukreyev A, Lamirande EW, Buchholz UJ, Vogel LN, Elkins WR, St Claire M, et al.: Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS. Lancet 2004;363:2122-2127.
2. Bisht H, Roberts A, Vogel L, Bukreyev A, Collins PL, Murphy BR, et al.: Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. Proc Natl Acad Sci USA 2004;101:6641-6646.
3. Buchholz UJ, Bukreyev A, Yang L, Lamirande EW, Murphy BR, Subbarao K, et al.: Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity. Proc Natl Acad Sci USA 2004;101:9804-9809.
4. Yang ZY, Kong WP, Huang Y, Roberts A, Murphy BR, Subbarao K, et al.: A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature 2004;428:561-564.
5. Cinat J Jr, Michaelis M, Hoever G, Preiser W, and Doerr HW: Development of antiviral therapy for severe acute respiratory syndrome. Antiviral Res 2005;66:81-97.
6. Peiris JS, Guan Y, and Yuen KY: Severe acute respiratory syndrome. Nat Med 2004;10:S88-S97.
7. Haagmans BL, Kuiken T, Martina BE, Fouchier RA, Rimmelzwaan GF, van Amerongen G, et al.: Pegylated interferon-α protects type 1 pneumocytes against SARS coronavirus infection in macaques. Nat Med 2004;10:290-293.
8. Keller MA, and Stiehm ER: Passive immunity in prevention and treatment of infectious diseases. Clin Microbiol Rev 2000;13:602-614.
9. Watt G, Kantipong P, Jongsakul K, de Souza M, and Burnouf T: Passive transfer of scrub typhus plasma to patients with AIDS: A descriptive clinical study. Q J Med 2001;94:599-607.
10. Savoldo B, Goss J, Liu Z, Huls MH, Doster S, Gee AP, et al.: Generation of autologous Epstein-Barr virus-specific cytotoxic T cells for adoptive immunotherapy in solid organ transplant recipients. Transplantation 2001;72:1078-1086.
11. Chiba T, Yokosuka O, Goto S, Fukai K, Imazeki F, Shishido H, et al.: Successful clearance of hepatitis B virus after allogeneic stem cell transplantation: Beneficial combination of adoptive immunity transfer and lamivudine. Eur J Haematol 2003;71:220-223.
12. Ferrantelli F, Rasmussen RA, Hofmann-Lehmann R, Xu W, McClure HM, and Ruprecht RM: Do not underestimate the power of antibodies: Lessons from adoptive transfer of antibodies against HIV. Vaccine 2002;20(Suppl 4):A61-A65.
13. Dahmen U, Dirsch O, Li J, Fiedle M, Lu M, Rispeter K, et al.: Adoptive transfer of immunity: A new strategy to interfere with severe hepatitis virus reinfection after woodchuck liver transplantation. Transplantation 2004;77:965-972.
14. Soo YO, Cheng Y, Wong R, Hui DS, Lee CK, Tsang KK, et al.: Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients. Clin Microbiol Infect 2004;10:676-678.
15. Subbarao K, McAuliffe J, Vogel L, Fahle G, Fischer S, Tatti K, et al.: Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice. J Virol 2004;78:3572-3577.
16. Lang J, Attanath P, Quiambao B, Singhasivanon V, Chanthavanich P, Montalban C, et al.: Evaluation of the safety, immunogenicity, and pharmacokinetic profile of a new, highly purified, heat-treated equine rabies immunoglobulin, administered either alone or in association with a purified, Vero-cell rabies vaccine. Acta Trop 1998;70:317-333.
17. Wang X, Ni B, Du X, Zhao G, Gao W, Shi X, et al.: Protection of mammalian cells from severe acute respiratory syndrome coronavirus infection by equine neutralizing antibody. Antiviral Ther 2005;10:681-690.
18. Takasuka N, Fujii H, Takahashi Y, Kasai M, Morikawa S, Itamura S, et al.: A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice. Int Immunol 2004;16:1423-1430.
19. Tsunetsugu-Yokota Y, Ohnishi K, and Takemori T: Severe acute respiratory syndrome (SARS) coronavirus: application of monoclonal antibodies and development of an effective vaccine. Rev Med Virol 2006;16:117-131.
20. Weingart H, Czub M, Czub S, Neufeld J, Marszal P, Gren J, et al.: Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets. J Virol 2004;78:12672-12676.
21. Roberts A, Vogel L, Guarner J, Hayes N, Murphy B, Zaki S, et al.: Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters. J Virol 2005;79:503-511.
22. Roberts A, Paddock C, Vogel L, Butler E, Zaki S, and Subbarao K: Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans. J Virol 2005;79:5833-5838.
23. Martina BE, Haagmans BL, Kuiken T, Fouchier RA, Rimmelzwaan GF, Van Amerongen G, et al.: Virology: SARS virus infection of cats and ferrets. Nature 2003;425:915.
24. Rowe T, Gao G, Hogan RJ, Crystal RG, Voss TG, Grant RL, et al.: Macaque model for severe acute respiratory syndrome. J Virol 2004;78:11401-11404.
25. McAuliffe J, Vogel L, Roberts A, Fahle G, Fischer S, Shieh WJ, et al.: Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys. Virology 2004;330:8-15.
26. Peiris JS, Chu CM, Cheng VC, Chan KS, Hung IF, Poon LL, et al.: Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: A prospective study. Lancet 2003;361:1767-1772.
27. Wang WK, Chen SY, Liu IJ, Kao CL, Chen HL, Chiang BL, et al.: Temporal relationship of viral load, ribavirin, interleukin (IL)-6, IL-8, and clinical progression in patients with severe acute respiratory syndrome. Clin Infect Dis 2004;39:1071-1075.
28. Ho MS, Chen WJ, Chen HY, Lin SF, Wang MC, Di J et al.: Neutralizing antibody response and SARS severity. Emerg Infect Dis 2005;11:1730-1737.
29. Roberts A, Thomas WD, Guarner J, Lamirande EW, Babcock GJ, Greenough TC, et al.: Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters. J Infect Dis 2006;193:685-692.
30. Duan J, Yan X, Guo X, Cao W, Han W, Qi C, Feng J, Yang D, Gao G, and Jin G: A human SARS-CoV neutralizing antibody against epitope on S2 protein. Biochem Biophys Res Commun 2005;333:186-193.
31. Sui J, Li W, Roberts A, Matthews LJ, Murakami A, Vogel L, Wong SK, Subbarao K, Farzan M, and Marasco WA: Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants. J Virol 2005;79:5900-5906.
32. Traggiai E, Becker S, Subbarao K, Kolesnikova L, Uematsu Y, Gismondo MR, Murphy BR, Rappuoli R, and Lanzavecchia A: An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat Med 2004;10:871-875.
33. Sui J, Li W, Murakami A, Tamin A, Matthews LJ, Wong SK, Moore MJ, Tallarico AS, Olurinde M, Choe H, Anderson LJ, Bellini WJ, Farzan M, and Marasco WA: Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. Proc Natl Acad Sci USA 2004;101:2536-2541.
34. ter Meulen J, Bakker AB, van den Brink EN, Weverling GJ, Martina BE, Haagmans BL, Kuiken T, de Kruif J, Preiser W, Spaan W, Gelderblom HR, Goudsmit J, and Osterhaus AD: Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets. Lancet 2004;363:2139-2141.